Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Human pilot evidence Three small pilots: a 12-patient knee-pain case series (Lee & Padgett, Alternative Therapies in Health and Medicine, 2021)
)
Head to Pomegranates site and start the intake questionnaire
)
Niya Mansuri, weight loss expert at myBMI Wegovy 0.25 mg, FlexTouch solution for injection in pre-filled pen (2026) EMC [accessed 9 March 2026] Ozempic 0.25 mg solution for injection in pre-filled pen (2025) EMC [accessed 9 March 2026] Non-alcoholic fatty liver disease (NAFLD) (2025) NHS [accessed 9 March 2026] Sleep apnoea (2022) NHS [accessed 9 March 2026] Physical activity guidelines for adults aged 19 to 64 (2024) NHS [accessed 9 March 2026] Semaglutide for managing overweight and obesity (2023) NICE [accessed 9 March 2026] Tirzepatide for managing overweight and obesity (2025) NICE [accessed 9 March 2026] Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial (2025) National Library of Medicine [accessed 9 March 2026] Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension (2022) National Library of Medicine [accessed 9 March 2026] Wegovy (2025) Novo Nordisk [accessed 9 March 2026] Its natural to have questions, and were here to keep things straightforward so you can stay focused on your journey
The use of "GLP-1" terminology in supplement marketing reflects conceptual positioning and does not indicate FDA approval, physiological equivalence, or interaction with prescription GLP-1 medications
US$ 28.64
US$ 22.18
US$ 27.12
US$ 22.16
US$ 27.76
US$ 24.71
